Developmental toxicity study of mangafodipir trisodium injection (MnDPDP) in New Zealand White rabbits

Fundamental and Applied Toxicology

Volumn 33, Issue 1, 1996, Pages 11-15

  Blazak, William F ^a   Brown, George L ^a   Gray, Tim J B ^b   Treinen, Kimberley A ^c,e   Denny, Kevin H ^d  

^a Nycomed Inc   (United States)

^b Sanofi Winthrop   (United Kingdom)

^c Sanofi Winthrop Inc   (United States)

^d Intl R and D Corporation   (United States)

^e GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; MANGAFODIPIR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FETOTOXICITY; FETUS; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PREGNANCY; RABBIT; SKELETON MALFORMATION; SPECIES DIFFERENCE; WEIGHT GAIN;

ANIMALIA; MAMMALIA; ORYCTOLAGUS CUNICULUS;

EID: 85033046456     PISSN: 02720590     EISSN: None     Source Type: Journal    
DOI: 10.1006/faat.1996.0137     Document Type: Article

References (12)

1. Dawson, A. B. (1926). Note on the staining of skeleton of cleared specimens with Alizarin red D. Stain Technol. 9, A37-A38.
2. Elizondo, G., Fretz, C. J., Stark, D. D., Rocklage, S. M., Quay, S. C., Worah, D., Tsang, Y.-M., Chen, M. C-C., and Ferrucci, J. T. (1991). Preclinical evaluation of MnDPDP: New paramagnetic hepatobiliary contrast agent for MR imaging. Radiology 178, 73-78.
3. Grant, D., and Ege, T. (1995). Teratogenicity in the rat after repeated intravenous injection of manganese, either as a complex (mangafodipir trisodium, MnDPDP), or as the inorganic chloride. Toxicologist 15, 160.
4. Grant, D., Holtz, E., and Shaw, D. (1994a). Pre-clinical safety assessment of MnDPDP, a new hepatobiliary MRI contrast agent. Acta Radiol. 35 (suppl. 394), 48.
5. Grant, D., Zech, K., and Holtz, E. (1994b). Biodistribution and in vivo stability of manganese dipyridoxal diphosphate in relation to imaging efficacy. Invest. Radiol. 29 (suppl. 2), S249-S250.
6. Hamm, B., Vogl, T. J., Branding, G., Schnell, B., Taupitz, M., Wolf, K.-J., and Lissner, J. (1992). Focal liver lesions: MR imaging with Mn-DPDP - Initial clinical results in 40 patients. Radiology 182, 167-174.
7. Lang, P. (1993). Historical Control Data for Development and Reproductive Toxicity Studies Using the New Zealand White Rabbit, pp. 18-19. HRP, Inc., Denver, PA.
8. Nau, H. (1987). Species differences in pharmacokinetics, drug metabolism, and teratogenesis. In Pharmacokinetics and Teratogenesis (H. Nau and W. J. Scott, Jr., Eds.), Vol. I, pp. 81-106. CRC Press, Boca Raton, FL.
9. Sanchez, D. L., Domingo, J. L., Llobet, J. M., and Keen, C. L. (1993). Maternal and developmental toxicity of manganese in the mouse. Toxicol. Lett. 69, 45-52.
10. Treinen, K. A., and Blazak, W. F. (1995). Developmental toxicity of WIN 59010-2 in Sprague Dawley rats. Toxicologist 15, 160-161.
11. Treinen, K. A., Gray, T. J. B., and Blazak, W. F. (1995). Developmental toxicity of mangafodipir trisodium and manganese chloride in Sprague Dawley rats. Teratology 52, 109-115.
12. Webster, W. S., and Valois, A. A. (1987). Reproductive toxicology of manganese in rodents, including exposure during the postnatal period. Neurotoxicology 8, 437-444.